Vyant Bio Provides Update on Winddown Activities
26 déc. 2023 09h15 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its...
Vyant Bio Announces Completion of StemoniX Asset Sale
24 oct. 2023 16h00 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT) announced that it has completed the sale of all or substantially all of the assets of the...